You need Java to see this applet.
This is the first website spotlight entirety on nanotechnology applications in drug
delivery. Provides a brief introduction to core nanotechnologies,like liposomes,
dendrimers, polymeric nanoparticles,drug nanoparticles,polymeric micelle,
carbon, carbon nanotubes etc.
Novavax Inc.
Featured Research
Headlines in NanoPharmaceuticals
Interview with

Dr. M. M. Amiji
University, Boston
Stimuvax Cancer Vaccine Phase III Study Begins
Merck KGaA announced that the first patient has been enrolled in its global
Phase III clinical study, START (Stimulating Targeted Antigenic
Responses To NSCLC), assessing the efficacy and safety of Stimuvax
(BLP25 liposome vaccine).....
NEW Feb, 2007.

Preclinical research studies to characterize the Pharmacological
profile of Relieva(R).  The in vitro studies to specifically determine the
immunoregulatory effects of Psorberine show  good results........
NEW Feb, 2007.

Report on the Future of Nanomedicine (3.1MB Adobe PDF file)
European science foundation’s forward look on Nanomedicine 2005, A

Nanotechnology in Health Care to 2009
This study analyzes the $906 million US market for nanotechnology in
health care products. It presents historical demand data  and forecasts.  
The study also considers market environment trends and indicators, details
industry structure and profiles 73 industry participants

Nanotechnology and the Developing World by Peter A. Singer Et al.,
Report show that developing countries are already harnessing
nanotechnology to address some of their most pressing needs and identify
and rank the ten applications of nanotechnology most likely to benefit
developing countries.
Reports on NanoPharmaceuticals

Contact us to
Your   Event
FDA Regulation

FDA Perspective
Link Partners
Nano Tsunami
About us | Advertising | Contact us
© 2005-2006 All rights reserved. No part of this Internet site may be reproduced
without prior written permission of the copyright holder.
Terms & Disclaimer

Nanopharmaceuticalas Online Journal

"Death by Nanoparticles" by, Dusica Maysinger Et al
News Archives